Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series

Regulatory agencies require evidence that endpoints correlate with clinical benefit before they can be used to approve drugs. Biomarkers are often considered surrogate endpoints. In cancer cachexia trials, the measurement of biomarkers features frequently. The aim of this systematic review was to as...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Yule, Michael S, Thompson, Joshua, Leesahatsawat, Khachonphat, Sousa, Mariana S, Anker, Stefan D, Arends, Jann, Balstad, Trude Rakel, Brown, Leo R, Bye, Asta, Dajani, Olav, Fallon, Marie, Hjermstad, Marianne Jensen, Jakobsen, Gunnhild, McDonald, James, McGovern, Josh, Roeland, Eric J, Sayers, Judith, Skipworth, Richard J.E, Ottestad, Inger, Philips, Iain, Simpson, Melanie Rae, Solheim, Tora S, Vagnildhaug, Ola Magne, McMillan, Donald, Laird, Barry J, Dolan, Ross D
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!